医学
肾脏疾病
肺动脉高压
重症监护医学
肺病
疾病
内科学
心脏病学
作者
Shanshan Yuan,Shicheng Li,Jiawen Ruan,Hongyan Dai,Tongmeng Jiang,Hongyan Dai
标识
DOI:10.1016/j.trsl.2024.06.003
摘要
Pulmonary hypertension (PH) is a medical condition characterized by elevated pulmonary vascular resistance and pressure, resulting from different diseases. Due to their high occurrence of PH, intricate hemodynamic classification, and frequently multifactorial cause and mechanism, individuals suffering from chronic kidney disease (CKD) are categorized as the fifth primary group of PH. Based on both domestic and international research, this article provides information on the epidemiology, risk factors, pathogenesis, and targeted drug treatment of PH associated with CKD.
科研通智能强力驱动
Strongly Powered by AbleSci AI